本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

15.67
+0.44002.89%
盤後15.670.00000.00%16:20 EDT
成交量:39.64萬
成交額:622.15萬
市值:12.79億
市盈率:-4.70
高:15.94
開:15.17
低:14.98
收:15.23
資料載入中...
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/06

重要事件披露

8-K - Current report
2023/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/19

重要事件披露

8-K - Current report
2022/08/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/16

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/08/16

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/08/16

重要事件披露

8-K - Current report
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/23

重要事件披露

8-K - Current report
2022/06/10

重要事件披露

8-K - Current report
2022/05/31

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report